Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma
NCT02863471
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Adenocarcinomas of the Pancreas
Interventions
DRUG:
Gemcitabine
Sponsor
University Hospital Tuebingen